Picture of CSPC Pharmaceutical logo

1093 CSPC Pharmaceutical Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapContrarian

Momentum

Relative Strength (%)
1m-22.85%
3m-30.15%
6m-29.16%
1yr-26.36%
Volume Change (%)
10d/3m+11.94%
Price vs... (%)
52w High-37.25%
50d MA-15.82%
200d MA-25.28%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)7.76
PEG Ratio (f)1.48
EPS Growth (f)5.52%
Dividend Yield (f)4.87%
Valuation (ttm)IndustryMarket
Price to Book Value1.44
Price to Tang. Book1.55
Price to Free Cashflow21.94
Price to Sales1.53
EV to EBITDA4.68

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital20.75%
Return on Equity18.03%
Operating Margin23.66%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueCNYm22,103.1924,942.227,866.8730,936.931,450.1132,823.3834,684.1912.16%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+23.79+28.19+14.87+9.08-3.19+5.49+5.53n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of CSPC Pharmaceutical EPS forecast chart

Profile Summary

CSPC Pharmaceutical Group Ltd is an investment holding company primarily engaged in the manufacture and sale of pharmaceutical products. The Company operates its business through three segments. The Finished Drugs segment in engaged in the research and development, manufacture and sale of pharmaceutical products and licensing business. The Bulk Products segment is engaged in the manufacture and sale of vitamin C, and antibiotic products in bulk powder form. The Functional Food and Others segment is engaged in the manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. The Company’s product therapeutic areas include nervous system, oncology, anti-infectives, cardiovascular, respiratory system, digestion and metabolism and others. The Company conducts its business in the domestic and overseas markets.

Directors

Last Annual
December 31st, 2023
Last Interim
June 30th, 2024
Incorporated
June 16th, 1992
Public Since
June 21st, 1994
No. of Employees
20,300
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
hk flag iconStock Exchange of Hong Kong Limited
Shares in Issue
11,859,741,732

1093 Share Price Performance

Upcoming Events for 1093

Dividend For 1093.HK - 0.1600 HKD

Dividend For CSPCY.PK - 0.0821 USD

Q3 2024 CSPC Pharmaceutical Group Ltd Earnings Release

Similar to 1093

Picture of 3D Medicines logo

3D Medicines

hk flag iconStock Exchange of Hong Kong Limited

Picture of 3SBio logo

3SBio

hk flag iconStock Exchange of Hong Kong Limited

Picture of AIM Vaccine Co logo

AIM Vaccine Co

hk flag iconStock Exchange of Hong Kong Limited

Picture of Ascletis Pharma logo

Ascletis Pharma

hk flag iconStock Exchange of Hong Kong Limited

Picture of Asymchem Laboratories Tianjin Co logo

Asymchem Laboratories Tianjin Co

hk flag iconStock Exchange of Hong Kong Limited

FAQ